SCHEMBL10484184

SCHEMBL10484184

O=C(O)c1ccc2ccc3c4ccccc4ccc3c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.67
GRIN2A Q12879 1/20 0.67
GRIN2C Q14957 1/20 0.67
ALDH1A1 P00352 4/20 0.58
MAPT P10636 2/20 0.58
HPGD P15428 2/20 0.58
HPRT1 P00492 1/20 0.54
PTPN1 P18031 1/20 0.53
PLA2G2D Q9UNK4 1/20 0.53
CASP3 P42574 1/20 0.51
GFER P55789 1/20 0.51
SENP8 Q96LD8 1/20 0.51
SENP7 Q9BQF6 1/20 0.51
SENP6 Q9GZR1 1/20 0.51
PARP1 P09874 1/20 0.51
HSD17B10 Q99714 4/20 0.50
HIF1A Q16665 2/20 0.50
CYP1B1 Q16678 1/20 0.50
CSNK2A1 P68400 1/20 0.49
KDM4E B2RXH2 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15439625 1.00 GRIN2D (0.67) GRIN2DGRIN2AGRIN2CALDH1A1MAPT
SCHEMBL31742339 1.00 GRIN2D (0.67) GRIN2DGRIN2AGRIN2CALDH1A1MAPT
SCHEMBL2469905 0.96 GRIN2D (0.66) GRIN2DGRIN2AGRIN2CALDH1A1MAPT
SCHEMBL10484311 0.92 ALDH1A1 (0.68) GRIN2DGRIN2AGRIN2CALDH1A1MAPT
SCHEMBL2469662 0.90 ALDH1A1 (0.70) GRIN2DGRIN2AGRIN2CALDH1A1MAPT
Bromide SCHEMBL7585583 0.89 ALDH1A1 (0.68) GRIN2DGRIN2AGRIN2CALDH1A1MAPT
SCHEMBL6345911 0.86 GRIN2D (0.59) GRIN2DGRIN2AGRIN2CALDH1A1MAPT
SCHEMBL10012998 0.86 GRIN2D (0.59) GRIN2DGRIN2AGRIN2CALDH1A1MAPT
SCHEMBL2343264 0.86 GRIN2D (0.61) GRIN2DGRIN2AGRIN2CALDH1A1HPGD
SCHEMBL19177351 0.86 GRIN2D (0.61) GRIN2DGRIN2AGRIN2CALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2953960-A1 C-19 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY Bristol-Myers Squibb Company (US) 2015-12-16 EP disclosed
WO-2014123889-A1 C-19 MODIFIED TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-14 WO disclosed
EP-2675526-A1 NOVEL SULFONAMINOQUINOLINE HEPCIDIN ANTAGONISTS Vifor (International) AG (CH) 2013-12-25 EP disclosed
WO-2013160810-A2 NOVEL BETULINIC ACID DERIVATIVES AS HIV INHIBITORS HETERO RESEARCH FOUNDATION (IN) 2013-10-31 WO disclosed
WO-2012110603-A1 NOVEL SULFONAMINOQUINOLINE HEPCIDIN ANTAGONISTS VIFOR (INTERNATIONAL) AG (CH) 2012-08-23 WO disclosed
US-4829090-A SECONDARY AMINES, ANTITUMOR BURROUGHS WELLCOME CO. (US) 1989-05-09 US disclosed
US-4810727-A ANTITUMOR BURROUGHS WELLCOME CO. (US) 1989-03-07 US disclosed
EP-0125701-B1 POLYCYCLIC AROMATIC COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1988-08-03 EP disclosed
US-4719048-A ANTITUMOR BURROUGHS WELLCOME CO. (US) 1988-01-12 US disclosed
US-4719046-A ANTITUMOR BURROUGHS WELLCOME CO. (US) 1988-01-12 US disclosed
EP-0125701-A2 Polycyclic aromatic compounds THE WELLCOME FOUNDATION LIMITED (GB) 1984-11-21 EP disclosed